New InnomarLive Announced for September: Real-World Evidence

July 21, 2017


InnomarLive 2017 

Real-World Evidence: Driving Data to Demonstrate Value


The field of Real-World Evidence (RWE) is rapidly evolving as more pharmaceutical, biotech and medical device manufacturers turn to outcomes data to demonstrate the value of their product in today's healthcare system.

This InnomarLive will focus on Real-World Evidence and its impact on decision making for patients, public and private payers, and other industry stakeholders. Hear from our panel of thought leaders throughout the day and participate in interactive case studies that demonstrate how RWE is shaping practices in the healthcare sector. To register, click here.  

Session Breakdown:

  • International perspective
  • Experienced data analyst
  • Public and private payers
  • Manufacturer perspective
  • Health economics and outcomes research
  • Patient support programs
  • Interactive case studies facilitated by industry experts that examines how real-world evidence is synthesized, assessed, and utilized

Share: